中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
高能物理研究所 [367]
近代物理研究所 [174]
上海药物研究所 [116]
昆明植物研究所 [92]
地质与地球物理研究... [84]
西北高原生物研究所 [79]
更多
采集方式
OAI收割 [1433]
iSwitch采集 [423]
内容类型
期刊论文 [1826]
会议论文 [25]
EI期刊论文 [3]
学位论文 [1]
预印本 [1]
发表日期
2023 [26]
2022 [67]
2021 [111]
2020 [87]
2019 [167]
2018 [210]
更多
学科主题
Plant Sci... [23]
Physics [15]
Chemistry [13]
Ecology [12]
Pharmacol... [11]
Biochemist... [9]
更多
筛选
浏览/检索结果:
共1856条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
ANTITUMOR ACTIVITY OFGYTOGHALASIN D
期刊论文
OAI收割
JOURNAL OF ANTIBIOTICS, 2025, 页码: 722-723
作者:
Wen-Jie Guo
;
Guan-Jun Tao
;
Wen-Yi Tao
;
Feng-Jie Cui
;
Xian-Chun Jin
  |  
收藏
  |  
浏览/下载:207/0
  |  
提交时间:2017/07/19
SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors
期刊论文
OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 卷号: 9, 期号: 1, 页码: 13
作者:
Qian, Hui
;
Ding, Chen-Hong
;
Liu, Fang
;
Chen, Shi-Jie
;
Huang, Chen-Kai
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2024/05/22
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1
期刊论文
OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 卷号: 9, 期号: 1, 页码: 14
作者:
Xie, Xiong
;
Lan, Qiaoshuai
;
Zhao, Jinyi
;
Zhang, Sulin
;
Liu, Lu
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2024/05/07
A truncated test scheme design method for success-failure in-orbit tests
期刊论文
OAI收割
Reliability Engineering and System Safety, 2024, 卷号: 243
作者:
Ding, Wenzhe
;
Bai, Xiang
;
Wang, Qingwei
;
Long, Fang
;
Li, Hailin
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2023/12/07
IOT verification test
Sequential test
Bayesian theory
Risk calculation
Optimization
A spectral data release for 104 type II supernovae from the Tsinghua Supernova group
期刊论文
OAI收割
MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY, 2024, 卷号: 528, 期号: 2, 页码: 3092-3129
作者:
Lin H(林含)
;
Wang, Xiaofeng
;
Zhang JJ(张居甲)
;
Yan, Shengyu
;
Xiang, Danfeng
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2024/03/29
techniques: spectroscopic
surveys
supernovae: general
A Near-infrared Fluorescence and Positron Emission Tomography Bimodal Probe for
I
n Vivo
I
maging of Amyloid-β Species
期刊论文
OAI收割
ACS CHEMICAL NEUROSCIENCE, 2024, 卷号: 15, 期号: 3, 页码: 472-478
作者:
Fang, Daqing
;
Pan, Donghui
;
Wen, Xidan
;
Zhang, Junya
;
Yang, Min
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2024/03/13
A beta species
Alzheimer's disease
NIR fluorescence imaging
PET imaging
bimodalprobe
APP/PS1
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects
期刊论文
OAI收割
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 卷号: 191, 页码: 9
作者:
Yang, Xin-Mei
;
Yang, Yang
;
Yao, Bu-Fan
;
Ye, Pan-Pan
;
Xu, Yan
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2023/12/11
COVID-19
Simnotrelvir
Safety
Pharmacokinetics
Healthy subjects
Structure-based drug discovery of novel fused- pyrazolone carboxamide derivatives as potent and selective AXL inhibitors
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4918-4933
作者:
Fang, Feifei
;
Dai, Yang
;
Wang, Hao
;
Ji, Yinchun
;
Liang, Xuewu
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2024/01/26
derivatives
Antitumor drug development
Potential AXL inhibitor
Antitumor activity
Structure-based drug design
Fused-pyrazolone carboxamide
Automatic Target Description File Generation
期刊论文
OAI收割
JOURNAL OF COMPUTER SCIENCE AND TECHNOLOGY, 2023, 卷号: 38, 期号: 6, 页码: 1339-1355
作者:
Geng, Hong-Na
;
Lyu, Fang
;
Zhong, Ming
;
Cui, Hui-Min
;
Xue, Jingling
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2024/05/20
retargetability
compiler
target description
target backend
automatic generator
Original Research Response to programmed cell death protein 1 antibody in patients with Epstein-Barr virus-associated intrahepatic cholangiocarcinoma
期刊论文
OAI收割
EUROPEAN JOURNAL OF CANCER, 2023, 卷号: 194, 页码: 9
作者:
He, Wen-Zhuo
;
Huang, Yu-Hua
;
Hu, Wan-Ming
;
Wang, Fang
;
Xu, Yu-Xia
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2023/12/11
Epstein-Barr virus
Intrahepatic cholangiocarcinoma
Programmed cell death protein 1
Immunotherapy